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A B S T R A C T
Our patient is a 65-year-old man with a history of hypertension, aortic stenosis, and end-stage renal
disease on hemodialysis who presented with worsening dyspnea. On examination, he exhibited signs of
volume overload and had a radiocephalic arteriovenous ﬁstula (AVF) with a signiﬁcantly palpable thrill.
Coronary angiogram showed normal coronary arteries. Cardiac catheterization revealed a cardiac output
of 10.6 L/min by thermodilution. Ultrasound of the AVF access demonstrated an abnormally high
velocity with ﬂow >5 L/min.
The patient was diagnosed with high-output heart failure (HOHF) secondary to his arteriovenous ﬁstula.
HOHF is an uncommon entity associated with certain pathologic states such as hyperthyroidism, skeletal
and dermatologic disorders. It is deﬁned as a high cardiac output >8 L/min, resting cardiac index >2.5–
4.0 L/min per m2, and low systemic vascular resistance. Cardiac catheterization is often required for
deﬁnitive diagnosis. The increased cardiac output may result in overt heart failure in patients with
underlying heart disease. Treatment of HOHF secondary to an extracardiac shunt involves ﬂow reduction
procedures, ligation, or peritoneal dialysis. Our patient was successfully treated with AVF banding. Early
recognition of this complication is critical, as many cases are reversible.
<Learning objective: High-output heart failure, deﬁned as cardiac output >8 L/min, resting cardiac
index >2.5–4.0 L/min per m2 and low systemic vascular resistance, is an uncommon entity associated
with conditions such as hyperthyroidism, skeletal disorders, and dermatologic disorders. It is an often-
missed complication in patients with arteriovenous ﬁstulas, particularly those with underlying heart
disease. The Kidney Foundation guidelines recommend arteriovenous ﬁstula monitoring by physical
examination and monthly ﬂow measurements for patients at risk.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Most patients with heart failure have systolic dysfunction with
a low or normal cardiac output and elevated systemic vascular
resistance or diastolic dysfunction due to increased ventricular
stiffness that impairs ventricular ﬁlling during diastole. In rare
circumstances, however, the cardiac output is elevated and the
calculated systemic vascular resistance is low, such as with high-
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roidism, Paget’s disease, and psoriasis [1–4]. We describe the case
of a patient diagnosed with high-output heart failure secondary to
a high-ﬂow arteriovenous ﬁstula (AVF).
Case report
Our patient is a 65-year-old man with hypertension, aortic
stenosis, a 60-pack year smoking history, and end-stage renal
disease on hemodialysis via a right radiocephalic AVF placed
2 years previously, who presented with worsening dyspnea over
several days. Of note, he had two prior admissions to an outside
hospital for dyspnea over the past year, which were attributed to
asthma exacerbation. On admission, he was afebrile, with oxygen
saturation of 80% on room air, blood pressure of 197/103 mmHg,s reserved.
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ﬁne, wet, bibasilar inspiratory crackles, diminished second heart
sound, and a grade 3/6 mid-systolic murmur heard throughout the
precordium radiating to the carotid arteries. The carotid arterial
pulse was noted to have a delayed peak with gradual down-
sloping. Lower extremities were notable for 2+ pitting edema
bilaterally up to the mid-calves. On the right upper extremity, a
radiocephalic AVF with a signiﬁcantly palpable thrill was promi-
nent. Laboratory values were signiﬁcant for a brain natriuretic
peptide level of 5386 pg/mL and negative cardiac enzymes
including creatine kinase-MB, which was undetectable and
troponins, which were within the normal range. Chest radiograph
showed cardiomegaly and mild pulmonary vascular congestion. A
12-lead electrocardiogram showed left ventricular hypertrophy
with repolarization changes, a prolonged QT interval at 510 ms and
a non-speciﬁc intra-ventricular conduction delay (Fig. 1).
He was treated with intravenous furosemide, bilevel positive
airway pressure, and nitroglycerin intravenous infusion with some
improvement in his symptoms. He received dialysis as scheduled.
Aortic valve replacement (AVR) was considered on presentation
given previous admissions for pulmonary edema and a recent
echocardiogram revealing a peak velocity of greater than 4 m/s
across the aortic valve. The patient’s signiﬁcantly palpable thrill on
physical examination and loud bruit auscultated over the AVF were
suggestive of a volume overload state. Thus, he underwent
ultrasound of the AVF access. An ultrasound duplex imager with
pulsed wave and color ﬂow Doppler was utilized. The graft was
scanned with the evaluation of the inﬂow artery in the transverse
view all the way to the outﬂow vein and then repeated with the
longitudinal view. The anastomosis was imaged with pulsed
Doppler waveforms; the peak systolic velocity and depth of the
access were measured. AVF ultrasound demonstrated a widely
patent right radiocephalic shunt with an abnormally high ﬂow
volume (greater than 5 L/min) (Fig. 2).
The patient was scheduled for a coronary angiogram prior to
AVR to assess for coronary artery disease. Coronary angiography
showed normal coronary arteries. A right heart catheterization
revealed a mean right atrial pressure of 18 mmHg, right ventricular
systolic pressure 68 mmHg, pulmonary artery (PA) pressuresFig. 1.
A 12-lead electrocardiogram demonstrating a heart rate of 95 bpm, sinus rhy
hypertrophy with repolarization changes, and evidence of a non-speciﬁc int65/32 mmHg, mean PA 46 mmHg, pulmonary capillary wedge
pressure 28 mmHg, and normal pulmonary vascular resistance.
Our patient’s right atrial waveforms, as shown in Fig. 3, demon-
strate a steep y descent, suggesting rapid atrial emptying. Cardiac
output was found to be 10.6 L/min by thermodilution. Cardiac
index was calculated to be 5.2 L/min per m2.
The patient was diagnosed with high-output heart failure
secondary to his AVF. He was treated with banding of the AVF
access, which resulted in a decrease in the ﬂow volume to 1.8 L/
min and moderate alleviation of symptoms. A month later he
underwent bioprosthetic AVR, which led to additional symptom-
atic improvement. The patient continues to receive hemodialysis
via his right radiocephalic AVF after banding.
Discussion
Certain physiologic states may lead to transient high cardiac
output such as stress, exercise, excitement, fever, and pregnancy.
However, high-output heart failure is an uncommon entity
associated with pathologic conditions such as hyperthyroidism,
beriberi, skeletal disorders such as Paget’s disease, and dermato-
logic disorders such as psoriasis [3,5]. In hyperthyroid states,
increased levels of thyroxine result in increased metabolism,
which results in reduced systemic vascular resistance. High cardiac
output then ensues. Beriberi heart disease due to severe thiamine
(vitamin B1) deﬁciency is more common in developing areas,
including certain parts of Asia such as Indonesia and Malaysia,
where the diet may include a high intake of polished rice deﬁcient
in thiamine. It may also occur in individuals in developed nations
who have liver disease and alcoholism or have undergone gastric
surgery. Exfoliative dermatitis, Kaposi’s sarcoma, and disseminat-
ed psoriasis can also result in elevated cardiac output secondary to
signiﬁcant cutaneous vascular dilatation and increased blood ﬂow
to the skin. Patients with multiple myeloma, polyostotic ﬁbrous
dysplasia, and osteitis deformans (Paget’s disease) may have many
minute AVFs in bony lesions [1,3,5]. Increased cardiac output can
result with extensive bone involvement of these lesions.
AVFs are being increasingly recognized as a cause of high-
output heart failure. In an AVF, blood from a high-pressure artery isthm, prolonged QT interval at 510 ms, electrographic evidence of left ventricular
raventricular conduction delay.
Fig. 2. Doppler ultrasonography demonstrating a widely patent upper extremity arteriovenous ﬁstula with abnormally high velocity ﬂow greater than 5 L/min.
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vascular resistance. In response to this, the heart rate and stroke
volume increase to compensate, and thus the total plasma volume
increases. Blood ﬂowing through the AVF bypasses the capillaries.
Therefore in order to maintain the capillary perfusion, the total
cardiac output has to increase [2].
High-output heart failure is deﬁned as a high cardiac output
>8 L/min, elevated resting cardiac index greater than 2.5–4.0 L/
min per m2, and low systemic vascular resistance [4,5]. Patients
may present with pulmonary or systemic venous congestion,
tachycardia, a bounding pulse, wide pulse pressure, a systolic bruit
over the carotid arteries, or an enlarged heart with a mid-systolic
murmur. Other physical examination ﬁndings include a cervical
venous hum, pistol-shot sounds heard over the femoral arteries
(Traube’s sign), and subungual capillary pulsations (Quincke’s
pulse). If one were to transiently occlude an AVF, this may increase
the arterial pressure, lower the venous pressure, and decrease the
heart rate (Nicoladoni–Branham’s sign) [6]. Cardiac examination
may also reveal a third heart sound due to the increased rate of
ventricular ﬁlling. These signs may be present in other conditions
that result in an increased stroke volume such as aortic
regurgitation or a patent ductus arteriosus [1,2]. However, in
the absence of these conditions, these ﬁndings are suggestive of
high-output heart failure. Our patient’s prominent thrill on
physical examination, loud bruit auscultated over the AVF, mid-
systolic murmur, bounding pulses, and pulmonary congestion
were initial clues to the diagnosis. Although he had aortic stenosis,
which can also cause pulmonary congestion and symptoms of
heart failure, his ﬁndings of signiﬁcantly increased cardiac output
and high ﬂow across the AVF suggest a concomitant diagnosis of
high-output heart failure.Fig. 3.
Right atrial waveforms. a, atrial contraction during ventricular diastole; x, rig
during ventricular systole; y, right ventricular relaxation and right atrial emAppropriate diagnostic testing should be ordered based on the
suspected cause of the high output as determined by the patient’s
history and physical examination. Cardiac catheterization with
measurement of intracardiac pressures and hemodynamic calcu-
lations is usually required for deﬁnitive diagnosis. The treatment
lies in correcting the underlying cause of the high output. For
patients with hyperthyroidism, anti-thyroid medications may be
administered; those with Beriberi should be given thiamine.
Vasodilators would not be beneﬁcial in these patients with a low
systemic vascular resistance. In some patients, dietary sodium
restriction and judicious use of diuretics may be considered [2].
The mechanism by which an AVF affects cardiac output is not
entirely understood. Moreover, the relationship between the
AVF blood ﬂow and the systemic blood ﬂow is not linear. As
noted in the literature, cardiac decompensation due to an AVF is
likely to occur only in patients with underlying cardiac disease.
Creation of an AVF has been associated with increased blood
ﬂow, pulmonary hypertension, and increased cardiac output. In
addition to increased cardiac output, it also results in decreased
systemic vascular resistance, thereby exerting a systemic effect.
High-output heart failure results when the arteriovenous blood
ﬂow (QA) signiﬁcantly exceeds 2 L/min. The cardio-pulmonary
recirculation, a ratio that compares the arteriovenous blood
ﬂow to the cardiac output, can be used to risk stratify patients.
A ratio greater than 0.3 is considered a risk factor for the
development of high-output heart failure [7].
Although not usually clinically signiﬁcant, the increased cardiac
output may result in overt heart failure in patients with underlying
heart disease, particularly if the shunt ﬂow is greater than 2 L/min.
Prospective monitoring for patients at risk is recommended. Those
at risk include patients with advanced age, those with a history ofht atrial relaxation; v, ﬁlling of the right atrium and bulging of the tricuspid valve
ptying.
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National Kidney Foundation guidelines recommend AVF monitor-
ing by physical examination weekly and monthly ﬂow measure-
ments for patients at risk. On physical examination, the presence
of a distended ﬁstula with a strong pulse and thrill, as in our
patient, is suspicious for high output. Other ﬁndings include a
wide pulse pressure, edema, warmth, erythema, and a machinery-
like murmur with a prominent thrill [6].
Treatment involves ﬂow reduction procedures such as ligation,
banding, and revision using distal ﬂow. In banding procedures,
the lumen near the arterial anastomosis is decreased in size by
applying suturing or prosthetic wrap. The advantage of this
procedure is potential salvage of the access. However, thrombosis
is relatively common after these procedures due to the increase in
turbulent ﬂow [8]. Other options include relocating the anasto-
mosis to a smaller, more distal artery, thereby allowing integration
of ﬂow in the ulnar artery and decreasing the anastomosis size. If
a patient is unable to tolerate the AVF revision, the anastomosis
can be ligated, and alternate options such as peritoneal dialysis
or use of a permanent indwelling catheter may be considered.
This is particularly the case for patients with New York Heart
Association class III or IV heart failure. Our patient was successfully
treated with banding of the AVF access.
As heart disease is a major risk factor for early death in
dialysis patients, the question arises whether an AVF access may
contribute to increased mortality. Clinicians should be aware of
this complication. Early recognition is critical as many cases are
reversible [2].
Conﬂict of interest
The authors declare no conﬂict of interest.Funding
No funding was received.
Acknowledgments
We extend our appreciation to Dr Steve Tsai and Dr Ralph
Oriscello for the exemplary learning opportunities provided
through the East Orange VA and the Rutgers New Jersey Medical
School Internal Medicine program.
Also, I thank Sabiha Imran for her continued support and
encouragement.
References
[1] Mehta PA, Dubrey SW. High output heart failure. QJM 2009;102:235–41.
[2] Bhave P, Foster E, Dhaliwal G. Clinical problem-solving. A missed connection.
N Engl J Med 2012;367:2241–7.
[3] Anderson CB, Codd JR, Graff RA, Groce MA, Harter HR, Newton WT. Cardiac
failure and upper extremity arteriovenous dialysis ﬁstulas. Case reports and a
review of the literature. Arch Intern Med 1976;136:292–7.
[4] Engelberts I, Tordoir JH, Boon ES, Schreij G. High-output cardiac failure due to
excessive shunting in a hemodialysis access ﬁstula: an easily overlooked
diagnosis. Am J Nephrol 1995;15:323–6.
[5] Stern AB, Klemmer PJ. High-output heart failure secondary to arteriovenous
ﬁstula. Hemodial Int 2011;15:104–7.
[6] Velez-Roa S, Neubauer J, Wissing M, Porta A, Somers VK, Unger P, Borne P. Acute
arteriovenous ﬁstula occlusion decreases sympathetic activity and improves
baroreﬂex control in kidney transplanted patients. Nephrol Dial Transplant
2004;19:1606–12.
[7] Basile C, Lomonte C, Vernaglione L, Casucci F, Antonelli M, Losurdo N. The
relationship between the ﬂow of arteriovenous ﬁstula and cardiac output in
haemodialysis patients. Nephrol Dial Transplant 2008;23:282–7.
[8] Cronenwett JL, Johnston KW, Rutherford RB. Hemodialysis access: nonthrom-
botic complications. Rutherford’s vascular surgery. 7th ed. Philadelphia, PA:
Saunders; 2010.
